Microbot Medical (Nasdaq:MBOT) announced today that it entered into an agreement with Emory University to look at autonomous surgical robotics. The collaboration aims to evaluate and explore the potential for autonomous robotics in endovascular procedures. Under the agreement, Emory assumes the responsibility of exploring the feasibility of integrating Microbot’s Liberty endovascular surgical robot with an […]
Microbot Medical
Microbot Medical enrolls first patient in surgical robot trial
Microbot Medical (Nasdaq:MBOT) today announced the completion of the first procedure in a clinical trial using its surgical robot system. Investigators in the company’s pivotal human clinical trial completed the procedure at Brigham and Women’s Hospital in Boston. They used the Braintree, Massachusetts-based company’s Liberty endovascular robotic surgical system. Dr. Dmitry Rabkin, the trial’s lead […]
FDA approves Microbot Medical endovascular surgical robot trial
Microbot Medical (Nasdaq:MBOT) this week announced it received FDA approval to start its human clinical trial for its Liberty Endovascular Robotic Surgical System. The pivotal human clinical trial is part of the company’s investigational device exemption application. It will be conducted in the U.S., and Microbot Medical has signed a clinical trial service agreement with “a […]
Microbot Medical submits surgical robot for FDA IDE
Microbot Medical (Nasdaq:MBOT) announced today that it filed an FDA investigational device exemption (IDE) application for its surgical robot. Braintree, Massachusetts-based Microbot designed the Liberty surgical robot for potential use in neurovascular, cardiovascular and peripheral vascular procedures. The system includes a compact design and remote operating capabilities to reduce radiation exposure and physical strain on […]
Microbot Medical settles investors’ lawsuit for more than $2M
Microbot Medical (Nasdaq: MBOT), the developer of the Liberty endovascular robotic surgical system, announced today that it has settled a years-old lawsuit involving a securities purchase agreement. Empery Asset Master, Empery Tax Efficient, Empery Tax Efficient II, and Hudson Bay Master Fund sued Microbot Medical in 2020 in the New York state court in New […]
Microbot Medical expands U.S. operations to prep for first in-human clinical study
Microbot Medical, the developer of the Liberty endovascular robotic surgical system, is building on the momentum from the positive results of its good laboratory practices (GLP) pre-clinical study. The company is adding a clinical research associate to support its pending investigational device exemption, or IDE, submission to commence its first-in-human clinical trial. The clinical research […]
Microbot Medical meets objectives in preclinical surgical robot study, seeks FDA IDE
Microbot Medical (Nasdaq:MBOT) today announced the successful completion of its GLP pivotal preclinical surgical robot study. Braintree, Massachusetts-based Microbot completed the study using a porcine model. It operated under the guidelines of FDA-required levels of planning, controlling, monitoring and reporting. Microbot said earlier this month that the study used its Liberty endovascular surgical robotic system […]
Microbot Medical, Corewell collab on telerobotics for endovascular surgical robot
Microbot Medical (Nasdaq:MBOT) announced today that it entered into a collaboration with Corewell Health to enable telerobotic capabilities. The collaboration, separated into multiple phases, seeks to enable telerobotics between remote centers. It aims to do so utilizing the Liberty endovascular robotic surgical system. The Braintree, Massachusetts-based company has plans to submit Liberty for FDA IDE approval […]
Microbot Medical is a step closer to an FDA IDE submission
Microbot Medical today announced the successful completion of its pivotal pre-clinical study of its Liberty endovascular robotic surgical system. The study, performed under good laboratory practice (GLP) and essential for the company’s investigational device exemption (IDE) submission, took place under rigorous FDA guidelines. The study involved pigs. In this study, three interventional radiologists performed 96 […]
Microbot Medical inks deal to expand surgical robot manufacturing capabilities
Microbot Medical (Nasdaq:MBOT) announcd today that it signed a manufacturing agreement with B.Y. Medimor for its surgical robot. Braintree, Massachusetts–based Microbot develops the Liberty single-use endovascular robotic surgical system. It designed Liberty for use in neurovascular, cardiovascular and peripheral vascular procedures. The system includes a compact design and remote operating capabilities to reduce radiation exposure […]
Microbot Medical completes pre-clinical study of endovascular surgical robot
Microbot Medical (Nasdaq:MBOT) announced today that it successfully completed an extended pre-clinical study of its surgical robot system. Hingham, Massachusetts-based Microbot develops the Liberty single-use endovascular robotic surgical system. It designed Liberty for use in neurovascular, cardiovascular and peripheral vascular procedures. The system includes a compact design and remote operating capabilities to reduce radiation exposure […]
